Related Articles
TBX2 expression is associated with platinum‑sensitivity of ovarian serous carcinoma
PRMT1 expression predicts sensitivity to platinum‑based chemotherapy in patients with ovarian serous carcinoma
Role of Fyn expression in predicting the sensitivity to platinum‑based chemotherapy in patients with ovarian serous carcinoma
Real‑time assessment of platinum sensitivity of primary culture from a patient with ovarian cancer with extensive metastasis and the platinum sensitivity enhancing effect by metformin
UCP2 expression may represent a predictive marker of neoadjuvant chemotherapy effectiveness for locally advanced uterine cervical cancer